Literature DB >> 9348751

Healthy aging. A women's issue.

A Z La Croix1, K M Newton, S G Leveille, J Wallace.   

Abstract

The life expectancy of women currently exceeds that of men by almost seven years, yet women spend approximately twice as many years disabled prior to death as their male counterparts. The diseases that account for death and health care utilization in older women (heart disease, cancer, stroke, fracture, pneumonia, osteoarthritis, cataracts) are also major contributors to disability. This paper reviews the scientific evidence that supports specific recommendations for older women that may prevent or delay these conditions for as long as possible. Risk factors for falls and fractures should be assessed and, where possible, modified. Adequate intakes of calcium, vitamin D, fruits, and vegetables should be encouraged. Weight should be monitored and weight loss discouraged for most women. Screening for B12 deficiency is recommended. Engaging women in a shared decision-making process about the use of hormone replacement therapy for longterm prevention of heart disease and fractures is important, as is regular screening for breast and colo-rectal cancer. Women should be encouraged to engage in enjoyable physical activities, including walking, for 30 minutes daily. These interventions have the potential to delay the onset and improve the course of many chronic conditions that prevail in later life.

Entities:  

Mesh:

Year:  1997        PMID: 9348751      PMCID: PMC1304535     

Source DB:  PubMed          Journal:  West J Med        ISSN: 0093-0415


  41 in total

1.  Women's beliefs and decisions about hormone replacement therapy.

Authors:  K M Newton; A Z LaCroix; S G Leveille; C Rutter; N L Keenan; L A Anderson
Journal:  J Womens Health       Date:  1997-08       Impact factor: 2.681

2.  Risk of endometrial cancer in relation to use of oestrogen combined with cyclic progestagen therapy in postmenopausal women.

Authors:  S A Beresford; N S Weiss; L F Voigt; B McKnight
Journal:  Lancet       Date:  1997-02-15       Impact factor: 79.321

3.  Duration of estrogen replacement therapy in relation to the risk of incident myocardial infarction in postmenopausal women.

Authors:  S R Heckbert; N S Weiss; T D Koepsell; R N Lemaitre; N L Smith; D S Siscovick; D Lin; B M Psaty
Journal:  Arch Intern Med       Date:  1997-06-23

4.  Estrogen replacement therapy and prognosis after first myocardial infarction.

Authors:  K M Newton; A Z LaCroix; B McKnight; R H Knopp; D S Siscovick; S R Heckbert; N S Weiss
Journal:  Am J Epidemiol       Date:  1997-02-01       Impact factor: 4.897

5.  A multisite field test of the acceptability of physical activity counseling in primary care: project PACE.

Authors:  B J Long; K J Calfas; W Wooten; J F Sallis; K Patrick; M Goldstein; B H Marcus; T L Schwenk; J Chenoweth; R Carter; T Torres; L A Palinkas; G Heath
Journal:  Am J Prev Med       Date:  1996 Mar-Apr       Impact factor: 5.043

Review 6.  Epidemiology of osteoporosis and osteoporotic fractures.

Authors:  S R Cummings; J L Kelsey; M C Nevitt; K J O'Dowd
Journal:  Epidemiol Rev       Date:  1985       Impact factor: 6.222

7.  Mediators of change in physical activity following an intervention in primary care: PACE.

Authors:  K J Calfas; J F Sallis; B Oldenburg; M Ffrench
Journal:  Prev Med       Date:  1997 May-Jun       Impact factor: 4.018

8.  Postmenopausal estrogen and progestin use and the risk of cardiovascular disease.

Authors:  F Grodstein; M J Stampfer; J E Manson; G A Colditz; W C Willett; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1996-08-15       Impact factor: 91.245

9.  Hip fracture and the use of estrogens in postmenopausal women. The Framingham Study.

Authors:  D P Kiel; D T Felson; J J Anderson; P W Wilson; M A Moskowitz
Journal:  N Engl J Med       Date:  1987-11-05       Impact factor: 91.245

10.  Menopause and the risk of coronary heart disease in women.

Authors:  G A Colditz; W C Willett; M J Stampfer; B Rosner; F E Speizer; C H Hennekens
Journal:  N Engl J Med       Date:  1987-04-30       Impact factor: 91.245

View more
  3 in total

Review 1.  Exercise, mobility and aging.

Authors:  M J Daley; W L Spinks
Journal:  Sports Med       Date:  2000-01       Impact factor: 11.136

Review 2.  Hormone replacement therapy, cancer, controversies, and women's health: historical, epidemiological, biological, clinical, and advocacy perspectives.

Authors:  Nancy Krieger; Ilana Löwy; Robert Aronowitz; Judyann Bigby; Kay Dickersin; Elizabeth Garner; Jean-Paul Gaudillière; Carolina Hinestrosa; Ruth Hubbard; Paula A Johnson; Stacey A Missmer; Judy Norsigian; Cynthia Pearson; Charles E Rosenberg; Lynn Rosenberg; Barbara G Rosenkrantz; Barbara Seaman; Carlos Sonnenschein; Ana M Soto; Joe Thornton; George Weisz
Journal:  J Epidemiol Community Health       Date:  2005-09       Impact factor: 3.710

3.  Sex-specific regulation of aging in Caenorhabditis elegans.

Authors:  Bernadette Hotzi; Mónika Kosztelnik; Balázs Hargitai; Krisztina Takács-Vellai; János Barna; Kincső Bördén; András Málnási-Csizmadia; Mónika Lippai; Csaba Ortutay; Caroline Bacquet; Angela Pasparaki; Tamás Arányi; Nektarios Tavernarakis; Tibor Vellai
Journal:  Aging Cell       Date:  2018-03-01       Impact factor: 9.304

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.